相似文献
1
Candida auris: a Review of the Literature.
Clin Microbiol Rev. 2017 Nov 15;31(1). doi: 10.1128/CMR.00029-17. Print 2018 Jan.
2
Candida auris: An emerging drug resistant yeast - A mini-review.
J Mycol Med. 2018 Sep;28(3):568-573. doi: 10.1016/j.mycmed.2018.06.007. Epub 2018 Jul 17.
3
Global epidemiology of emerging Candida auris.
Curr Opin Microbiol. 2019 Dec;52:84-89. doi: 10.1016/j.mib.2019.05.008. Epub 2019 Jul 3.
4
Candida auris-the growing menace to global health.
Mycoses. 2019 Aug;62(8):620-637. doi: 10.1111/myc.12904. Epub 2019 Jun 18.
5
Candida auris: Epidemiology, biology, antifungal resistance, and virulence.
PLoS Pathog. 2020 Oct 22;16(10):e1008921. doi: 10.1371/journal.ppat.1008921. eCollection 2020 Oct.
6
Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.
Clin Infect Dis. 2018 Jan 6;66(2):306-311. doi: 10.1093/cid/cix744.
7
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00238-18. Print 2018 Jun.
8
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20.
9
Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options.
Microb Pathog. 2018 Dec;125:116-121. doi: 10.1016/j.micpath.2018.09.014. Epub 2018 Sep 8.
10
[Candida auris: The Recent Emergence of a Multiresistant Pathogenic Fungi].
Acta Med Port. 2020 Oct 1;33(10):680-684. doi: 10.20344/amp.12419.
引用本文的文献
1
infection at a pediatric burn center: Treatment and infection control measures.
North Clin Istanb. 2025 Jun 11;12(3):285-289. doi: 10.14744/nci.2024.26429. eCollection 2025.
2
Successful management of Candida auris external ventricular shunt infection: a case report.
J Med Case Rep. 2025 Aug 5;19(1):393. doi: 10.1186/s13256-025-05088-3.
3
The calcineurin pathway regulates extreme thermotolerance, cell membrane and wall integrity, antifungal resistance, and virulence in Candida auris.
PLoS Pathog. 2025 Jul 28;21(7):e1013363. doi: 10.1371/journal.ppat.1013363. eCollection 2025 Jul.
4
Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery.
mBio. 2025 Aug 13;16(8):e0230324. doi: 10.1128/mbio.02303-24. Epub 2025 Jul 22.
5
Risk Factors for Among Admitted Patients in Riyadh, Saudi Arabia (2020-2022).
Infect Drug Resist. 2025 Jul 8;18:3369-3381. doi: 10.2147/IDR.S528127. eCollection 2025.
6
Exploring and evaluating the in vitro antifungal, antibiofilm and antitoxin efficacy of Artabotrys brachypetalus Benth. against Candida spp. and its toxicity in vivo assays.
BMC Complement Med Ther. 2025 Jul 10;25(1):258. doi: 10.1186/s12906-025-04877-z.
7
Understanding the mechanisms of resistance to azole antifungals in species.
JAC Antimicrob Resist. 2025 Jun 23;7(3):dlaf106. doi: 10.1093/jacamr/dlaf106. eCollection 2025 Jun.
8
Patterns and Predictors of Candidemia with Multidrug-Resistant Bacterial Co-Infections: Results from the CANDI-MDR Study.
J Fungi (Basel). 2025 May 25;11(6):407. doi: 10.3390/jof11060407.
9
Caged-hypocrellin mediated photodynamic therapy induces chromatin remodeling and disrupts mitochondrial energy metabolism in multidrug-resistant Candida auris.
Redox Biol. 2025 Jun 14;85:103708. doi: 10.1016/j.redox.2025.103708.
10
Managing Candida auris in dialysis units: challenges, strategies, and future directions.
Int Urol Nephrol. 2025 Jun 13. doi: 10.1007/s11255-025-04600-4.
本文引用的文献
1
First reported case of multidrug-resistant in Canada.
Can Commun Dis Rep. 2017 Jul 6;43(7-8):150-153. doi: 10.14745/ccdr.v43i78a02.
2
for the clinical microbiology laboratory: Not your grandfather's species.
Clin Microbiol Newsl. 2017 Jul 1;39(13):99-103. doi: 10.1016/j.clinmicnews.2017.06.003.
3
In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.
Mycoses. 2017 Nov;60(11):758-763. doi: 10.1111/myc.12699. Epub 2017 Sep 15.
4
Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
J Hosp Infect. 2017 Dec;97(4):371-375. doi: 10.1016/j.jhin.2017.08.019. Epub 2017 Sep 1.
5
Interactions of Echinocandins with Triazoles against Multidrug-Resistant .
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01056-17. Print 2017 Nov.
6
Effectiveness of Disinfectants Against Candida auris and Other Candida Species.
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1240-1243. doi: 10.1017/ice.2017.162. Epub 2017 Aug 10.
7
Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface.
J Clin Microbiol. 2017 Oct;55(10):2996-3005. doi: 10.1128/JCM.00921-17. Epub 2017 Jul 26.
8
Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species.
Infect Control Hosp Epidemiol. 2017 Sep;38(9):1107-1109. doi: 10.1017/ice.2017.127. Epub 2017 Jul 11.
9
Current perspective on emergence, diagnosis and drug resistance in .
Infect Drug Resist. 2017 Jun 7;10:155-165. doi: 10.2147/IDR.S116229. eCollection 2017.
10
Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00791-17. Print 2017 Aug.
Zotero 插件